5p15/ 9q22/ 15q22 Hyperdiploidy and Their Significance in Multiple Myeloma Patients
NCT06667583 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2024-11-01
Summary
Our study aims to detect 5p15/ 9q22/ 15q22 hyperdiploidy and thier significance in Multiple Myeloma patients
Conditions
- Multiple Myeloma, Neoplasms
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
dalia abd el naser, resident dr · Assiut University
-
Eman Zaki, Professor · Assiut University
-
safia hussein, Lecturer · Assiut University
-
mohammed El nagar, Ass profesor · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-01
- Primary Completion
- 2025-12-01
- Completion
- 2026-01-01
More Related Trials
-
Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
NCT06559033 ·Status: NOT_YET_RECRUITING
-
Optical Genome Mapping in Characterization of Multiple Myeloma
NCT05786105 ·Status: COMPLETED
-
Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
NCT00615628 ·Status: TERMINATED
-
Finistere Myeloma Observatory (OMYFIN)
NCT06552221 ·Status: COMPLETED
-
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
NCT07157579 ·Status: NOT_YET_RECRUITING
-
Clinical Evaluation of the Scopio Cell Morphology Technology
NCT06574308 ·Status: NOT_YET_RECRUITING
-
Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia
NCT01079507 ·Status: UNKNOWN
-
Cancer in Inherited Bone Marrow Failure Syndromes
NCT00027274 ·Status: RECRUITING
-
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias
NCT02643888 ·Status: UNKNOWN
-
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
NCT06883565 ·Status: COMPLETED
-
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma
NCT04212858 ·Status: UNKNOWN ·Phase: NA
-
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
NCT01454297 ·Status: COMPLETED
-
Genetic Analysis of Brain Tumors
NCT00031538 ·Status: TERMINATED
-
HLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan
NCT06665776 ·Status: RECRUITING
-
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
NCT00339963 ·Status: COMPLETED
-
Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.
NCT01079429 ·Status: TERMINATED
-
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
NCT03745378 ·Status: COMPLETED
-
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
NCT04546945 ·Status: RECRUITING
-
Study of DNA Samples From Patients With Multiple Myeloma
NCT00898040 ·Status: COMPLETED
-
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
NCT05831358 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
NCT05693012 ·Status: UNKNOWN
-
Characteristics and Outcomes of Patients With Hematological Malignancies
NCT06402175 ·Status: NOT_YET_RECRUITING
-
BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer
NCT02458664 ·Status: UNKNOWN
-
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins
NCT01563874 ·Status: COMPLETED
-
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
NCT01410981 ·Status: COMPLETED